Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice

Sleep

Volumn 36, Issue 1, 2013, Pages 31-40

  Blanco Centurion, Carlos ^b   Liu, Meng ^b   Konadhode, RodaRani ^b   Pelluru, Dheeraj ^b   Shiromani, Priyattam J ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cataplexy; sleep; Gene transfer; Hypocretin; Narcolepsy; Orexin; recombinant adenoassociated virus; REM sleep

Indexed keywords

GREEN FLUORESCENT PROTEIN; OREXIN; PARVOVIRUS VECTOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CATAPLEXY; CELL COUNT; CELL DENSITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; MUSCLE TONE; NARCOLEPSY; NERVE FIBER; NONHUMAN; NONREM SLEEP; PONS; PRIORITY JOURNAL; REM SLEEP; SLEEP WAKING CYCLE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT; WAKEFULNESS; WILD TYPE;

ANIMALS; CATAPLEXY; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FEMALE; GENE TRANSFER TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, KNOCKOUT; NARCOLEPSY; NEURONS; NEUROPEPTIDES; PONS;

EID: 84871895020     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2296     Document Type: Article

References (42)

1. Aldrich MS. The neurobiology of narcolepsy-cataplexy. Prog Neurobiol 1993; 41:533-41.
2. Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001; 18:78-105. (Pubitemid 32549906)
3. Anic-Labat S, Guilleminault C, Kraemer HC, Meehan J, Arrigoni J, Mignot E. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999;22:77-87. (Pubitemid 29097901)
4. Krahn LE, Lymp JF, Moore WR, Slocumb N, Silber MH. Characterizing the emotions that trigger cataplexy. J Neuropsychiatry Clin Neurosci 2005;17:45-50. (Pubitemid 40283769)
5. Longstreth WT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep 2007;30:13-26. (Pubitemid 46098865)
6. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
7. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
8. Thannickal TC, Nienhuis R, Siegel JM. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 2009;32:993-8.
9. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998;95:322-7. (Pubitemid 28103952)
10. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015. (Pubitemid 28543775)
11. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:1.
12. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40. (Pubitemid 30072183)
13. Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology 2005;65:1189-92. (Pubitemid 41508209)
14. Crocker A, Espana RA, Papadopoulou M, et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 2005;65:1184-8. (Pubitemid 41508208)
15. Liu M, Thankachan S, Kaur S, et al. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci 2008;28:1382-93.
16. Liu M, Blanco-Centurion C, Konadhode R, et al. Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice. J Neurosci 2011; 31:6028-40.
17. Siegel J. Brain mechanisms that control sleep and waking. Naturwissenschaften 2004;91:355-65. (Pubitemid 39215499)
18. Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 2004;101:4649-54. (Pubitemid 38437465)
19. Franklin BJK, Paxinos G. The mouse brain in stereotaxic coordinates, ed 2. Academic Press Inc, 1997 San Diego, CA USA.
20. Shiromani PJ, Xu M, Winston EM, Shiromani SN, Gerashchenko D, Weaver DR. Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. Am J Physiol Regul Integr Comp Physiol 2004;287:R47-R57. (Pubitemid 38856310)
21. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-51. (Pubitemid 29402482)
22. Shiromani PJ, McGinty DJ. Pontine neuronal response to local cholinergic infusion: relation to REM sleep. Brain Res 1986;386:20-31. (Pubitemid 17181456)
23. Henley K, Morrison AR. A re-evaluation of the effects of lesions of the pontine tegmentum and locus coeruleus on phenomena of paradoxical sleep in the cat. Acta Neurobiol Exp (Warsz) 1974;34:215-32.
24. Carter ME, Yizhar O, Chikahisa S, et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci 2010;13:1526-33.
25. Taghizadeh RR, Sherley JL. CFP and YFP, but not GFP, provide stable fluorescent marking of rat hepatic adult stem cells. J Biomed Biotechnol 2008;2008:453590.
26. Haseloff J, Amos B. GFP in plants. Trends Genet 1995;11:328-9.
27. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 1999;260:712-7.
28. Chudakov DM, Matz MV, Lukyanov S, Lukyanov KA. Fluorescent proteins and their applications in imaging living cells and tissues. Physiol Rev 2010;90:1103-63.
29. Thankachan S, Kaur S, Shiromani PJ. Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice. J Neurosci 2009;29:1580-5.
30. Shiromani PJ, Armstrong DM, Bruce G, Hersh LB, Groves PM, Gillin JC. Relation of pontine choline acetyltransferase immunoreactive neurons with cells which increase discharge during REM sleep. Brain Res Bull 1987;18:447-55. (Pubitemid 17045639)
31. Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981;1:876-86. (Pubitemid 11025876)
32. McGinty DJ, Harper RM. Dorsal raphe neurons: depression of firing during sleep in cats. Brain Res 1976;101:569-75.
33. Mochizuki T, Arrigoni E, Marcus JN, et al. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc Natl Acad Sci U S A 2011;108:4471-6.
34. Takahashi K, Lin JS, Sakai K. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 2006;26:10292-8. (Pubitemid 44527422)
35. Burgess CR, Tse G, Gillis L, Peever JH. Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy. Sleep 2010;33:1295-1304.
36. Gulyani S, Wu MF, Nienhuis R, John J, Siegel JM. Cataplexy-related neurons in the amygdala of the narcoleptic dog. Neuroscience 2002;112:355-65. (Pubitemid 34607019)
37. Poryazova R, Schnepf B, Werth E, et al. Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy. Sleep 2009;32:607-13.
38. Schwartz S, Ponz A, Poryazova R, et al. Abnormal activity in hypothalamus and amygdala during humor processing in human narcolepsy with cataplexy. Brain 2008;131:514-22. (Pubitemid 351197605)
39. Liu M, Blanco-Centurion C, Konadhode R, Pelluru D, Shiromani PJ. Orexin gene transfer in amygdala inhibits cataplexy in narcoleptic mice. Program No. 799.17. Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2012. Online.
40. Siegel JM, Nienhuis R, Fahringer HM, et al. Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla. Science 1991; 252:1315-8. (Pubitemid 21917048)
41. Magoun HW, Rhines R. An inhibitory mechanism in the bulbar reticular formation. J Neurophysiol 1946;9:165-71.
42. Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Muscle tone facilitation and inhibition after orexin-a (hypocretin-1) microinjections into the medial medulla. J Neurophysiol 2002;87:2480-9. (Pubitemid 34670719)